Juszczak, Edmund http://orcid.org/0000-0001-5500-2247
Hewer, Oliver
Partlett, Christopher
Hurd, Madeleine
Bari, Vasha
Bowler, Ursula
Linsell, Louise
Dorling, Jon
,
Bari, Vasha
Berrington, Janet
Bowler, Ursula
Boyle, Elaine
Dorling, Jon
Embleton, Nicholas
Hewer, Oliver
Hurd, Madeleine
Johnson, Samantha
Juszczak, Edmund
King, Andrew
Leaf, Alison
Linsell, Louise
McCormick, Kenny
McGuire, William
Murray, David
Partlett, Christopher
Roberts, Tracy
Stenson, Ben
Funding for this research was provided by:
Health Technology Assessment Programme (11/01/25)
Article History
Received: 16 May 2021
Accepted: 6 August 2021
First Online: 21 August 2021
Declarations
:
: The SIFT SWAT protocol was approved by the National Research Ethics Service (NRES) Committee East Midlands – Nottingham 2 on 20 December 2016 (reference 13/EM/0030).Parents who had not consented to participate in the two-year follow-up were excluded from the SWAT. For those that had consented to involvement in the follow-up, no additional consent was sought for the SWAT, because the parent information leaflet and the original consent process clearly indicated that the trial primary outcome was to be ascertained by questionnaire at 2 years of age corrected for prematurity.When parents were sent their questionnaire, they were explicitly informed of the incentives approach to which they had been allocated. It was felt that providing specific details to parents as to whether the incentive was conditional or unconditional would bias response rate and prevent assessment of the efficacy of the planned intervention. Withholding information about the other incentive arm was crucial for carrying out an unbiased study. However, a condition of ethics approval was that a debriefing sheet will be sent to parents detailing the results of the SWAT alongside the final SIFT results.
: All authors have confirmed that they consent to publication.
: All authors have completed the ICMJE uniform disclosure form at and declare: JD was a member of the NIHR HTA General Board (2017–18) and the NIHR HTA Maternity, Neonatal and Child Health Panel (2013–18). EJ was a member of the HTA Commissioning Board (2013–16), the NIHR HTA General Board (2016–17) and is presently a member of the NHS England and NIHR partnership programme (2019 to present). WM was a member of the NIHR HTA Commissioning Board (2013–2018) and is a member of the HTA Journals Editorial Board (2012–present). VB, JB, EB, UB, JD, NE, KM, WM, EJ, SJ, MH, OH, AK, AL, LL, DM, CP, BS, TR report funding from NIHR for the original SIFT trial. JB, UB, EB, JD, NE, EJ, SJ, OH, AK, LL, WM and TR report receipt of funding from NIHR, outside the submitted work.Other authors’ competing interests: Oliver Hewer reports personal fees from London School of Hygiene and Tropical Medicine, outside the submitted work.